Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis
Abstract Background Real-world data on subcutaneous C1INH (C1INH[SC]) usage and patient-level impacts on hereditary angioedema (HAE)-related outcomes and quality of life (QoL) are both lacking and challenging to generate using conventional study methodologies. Using a hybrid study design involving p...
Main Authors: | William Lumry, Timothy Craig, John Anderson, Marc Riedl, Henry Li, Raffi Tachdjian, Michael Manning, Paolo Bajcic, Frank Rodino, Sam Wang, Thomas R. Sexton, Jonathan A. Bernstein |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-023-00861-9 |
Similar Items
-
The latest therapeutic reports on short-term and long-term prophylaxis in the treatment of hereditary angioedema
by: Maciej Kozłowski, et al.
Published: (2024-02-01) -
Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience
by: Mohamed Abuzakouk, PhD, et al.
Published: (2022-07-01) -
Individual approach to long-term therapy in patients with hereditary angioedema (HAE-C1-INH): A case series
by: S. Andarawewa, et al.
Published: (2022-08-01) -
Hereditary angioedema prevalence and satisfaction with prophylaxis in South Australia
by: Alexander Troelnikov, MBBS, et al.
Published: (2024-07-01) -
Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasma-derived C1-inhibitor concentrate: a case report
by: D. V. Demina, et al.
Published: (2021-01-01)